BCWORLD PHARM. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3,524	5,884	5,444	6,996	4,032	2,756
Short-Term Investments	927	927	2,467	4,170	4,025	1,746
Cash & Short-Term Investments	4,451	6,811	7,911	11,166	8,058	4,503
Cash Growth	-37.68%	-13.91%	-29.14%	38.57%	78.97%	-64.15%
Accounts Receivable	17,318	18,736	20,297	18,190	16,511	15,047
Other Receivables	1,073	1,534	589.67	648.15	1,267	880.31
Receivables	18,390	20,270	20,887	19,483	17,778	15,927
Inventory	23,447	21,306	14,844	17,096	16,787	16,147
Prepaid Expenses	846.69	578.49	884.88	250.24	406.41	363.9
Other Current Assets	81.64	110.49	30.68	91.07	579.46	294.04
Total Current Assets	47,217	49,075	44,558	48,086	43,609	37,235
Property, Plant & Equipment	117,255	117,852	120,985	125,628	130,119	132,370
Long-Term Investments	1,758	2,616	2,921	1,784	1,362	3,756
Other Intangible Assets	2,468	2,544	2,711	2,997	2,828	2,266
Long-Term Deferred Tax Assets	4,357	4,511	4,946	5,459	4,979	3,145
Other Long-Term Assets	202.24	203.84	192.37	157.07	154.27	586.78
Total Assets	173,258	176,801	176,313	184,111	183,051	179,358
Accounts Payable	4,229	7,732	3,872	4,232	4,067	2,686
Accrued Expenses	3,616	4,392	3,915	425.32	456.14	556.95
Short-Term Debt	65,348	60,340	68,606	58,216	46,050	39,730
Current Portion of Long-Term Debt	5,750	11,917	5,653	21,433	26,817	5,405
Current Portion of Leases	341.38	340.99	256.72	196.82	62.87	66.58
Current Income Taxes Payable	296.06	495.83	84.71	136.93	-	133.13
Other Current Liabilities	5,395	4,496	3,477	7,606	6,753	7,314
Total Current Liabilities	84,975	89,713	85,865	92,246	84,206	55,892
Long-Term Debt	15,333	14,000	13,917	11,570	21,170	43,686
Long-Term Leases	559.97	567.5	521.27	424.88	154.87	132.15
Other Long-Term Liabilities	31.35	18.85	-0	0	0	-0
Total Liabilities	100,900	104,299	100,303	104,241	105,531	99,711
Common Stock	1,947	1,947	1,778	1,778	1,778	1,778
Additional Paid-In Capital	34,961	34,961	34,947	34,947	34,947	34,947
Retained Earnings	35,130	35,912	41,520	46,495	44,404	45,255
Treasury Stock	-1,354	-1,539	-1,578	-1,578	-1,578	-771.62
Comprehensive Income & Other	-0	-0	-0	-0	-0	248.54
Total Common Equity	70,684	71,281	76,668	81,643	79,552	81,458
Minority Interest	1,674	1,221	-657.38	-1,774	-2,032	-1,811
Shareholders' Equity	72,358	72,502	76,010	79,869	77,520	79,647
Total Liabilities & Equity	173,258	176,801	176,313	184,111	183,051	179,358
Total Debt	87,332	87,165	88,954	91,841	94,255	89,021
Net Cash (Debt)	-82,881	-80,354	-81,043	-80,675	-86,197	-84,518
Net Cash Per Share	-8952.03	-8648.57	-8739.62	-7901.05	-8359.02	-8180.51
Filing Date Shares Outstanding	10.09	9.29	9.28	10.21	10.21	10.33
Total Common Shares Outstanding	10.09	9.29	10.21	10.21	10.21	10.33
Working Capital	-37,758	-40,638	-41,307	-44,161	-40,597	-18,658
Book Value Per Share	7006.06	7669.36	7508.60	7995.86	7791.06	7884.29
Tangible Book Value	68,216	68,737	73,957	78,646	76,724	79,192
Tangible Book Value Per Share	6761.41	7395.66	7243.12	7702.33	7514.14	7664.98
Land	17,138	17,138	17,138	17,138	17,138	11,773
Buildings	66,295	66,789	68,819	71,974	73,792	51,199
Machinery	27,958	28,387	28,376	30,345	33,654	36,336
Construction In Progress	1,173	972.32	983.43	278.23	593.43	28,346